| Patents for C07J 43 - Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta[a]hydrophenanthrene skeleton (2,516) |
|---|
| 11/21/2002 | WO2001042273A9 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 11/21/2002 | CA2447032A1 Kinetic assay |
| 11/12/2002 | US6479476 Treating menopausal symptoms and osteoporosis in female warm-blooded animals |
| 11/06/2002 | EP1254179A1 An in vivo screen using chemical inducers of dimerization |
| 11/06/2002 | EP0639970B2 Contraception method using competitive progesterone antagonists and novel compounds useful therein |
| 10/31/2002 | US20020160972 Antisense compound with targeting and RNA cleaving moieties, preferably an imidazole functionality conjugated to the targeting oligonucleotide via linkers |
| 10/16/2002 | CN1374968A 4-benzylaminoquinoline conjugates with bile acid and their heteroanalogues, method fo r producing the same, medicaments containing these compounds and their use |
| 10/10/2002 | WO2002079220A2 Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation |
| 10/10/2002 | CA2438210A1 Steroid compounds, use of these compounds for the preparation of meiosis-regulating medicaments and method for the preparation of these compounds |
| 10/02/2002 | EP1245572A1 Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation |
| 09/24/2002 | US6455517 For therapy of conditions or diseases that are estrogen-dependent, i.e., are estrogen-induced or estrogen-stimulated |
| 09/19/2002 | WO2002072598A1 Steroids as agonists for fxr |
| 09/18/2002 | EP0630249B1 Dual action 2',5'-oligoadenylate antiviral derivatives and uses thereof |
| 09/18/2002 | CN1370179A Aromatic and heterocyclic derivatives of phytosterols and/or phytosanols for use in treating or preventing cardiovascular disease |
| 09/12/2002 | US20020128242 Novel cationic cholesteryl derivatives containing cyclic polar groups |
| 09/11/2002 | EP1238285A1 Steroid compounds for steroid receptor binding assays |
| 09/11/2002 | CN1368977A Unsaturated cholestane derivatives and their use for preparation of meiosis regulating medicaments |
| 09/10/2002 | CA2132449C 17 - substituted steroids useful in cancer treatment |
| 09/05/2002 | DE10109898A1 Lipide mit veränderlicher Ladung Lipids with variable charge |
| 09/04/2002 | EP1236471A2 Angiostatic steroids |
| 09/04/2002 | EP1236470A2 Angiostatic steroids |
| 09/04/2002 | EP1236469A2 Angiostatic steroids |
| 09/04/2002 | EP1235849A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 09/03/2002 | US6444683 17-azolyl steroids useful as androgen synthesis inhibitors |
| 08/29/2002 | WO2002066490A2 Cationic sterol derivatives, ph-sensitive liposomes comprising cationic sterol derivatives and method for loading liposomes with active substances |
| 08/29/2002 | WO2002066489A2 Amphoteric sterols and the use thereof in the production of ph-sensitive liposomes |
| 08/07/2002 | EP0885239B1 Novel steroid carbamates as potentiating agents |
| 08/01/2002 | US20020103392 Corticoid-17,21-dicarboxylic esters and corticosteroid 17-carboxylic ester 21-carbonic esters, processes for their preparation and pharmaceuticals containing these compounds |
| 07/31/2002 | EP0799059B1 Cationic amphiphiles and plasmids for intracellular delivery of therapeutic molecules |
| 07/24/2002 | CN1360591A 3 alpha-hydroxy-3 beta-methoxymethyl-21-heterocycle substd. steroids with anesthetic activity |
| 07/23/2002 | US6423700 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same |
| 07/18/2002 | WO2002055531A1 Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy |
| 07/11/2002 | US20020091278 Steroid derived antibiotics |
| 07/03/2002 | EP1218401A1 4-benzylaminoquinoline conjugates with bile acid and their heteroanalogues, methods for producing the same, medicaments containing these compounds and their use |
| 06/20/2002 | WO2002026759A3 17α FLUOROALKYL STEROIDS, METHOD FOR PRODUCING THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID COMPOUNDS |
| 06/18/2002 | US6407086 Novel sterol derivatives used for regulating the meiosis in oocytes and in male germ cells |
| 06/13/2002 | US20020072624 As antiestrogenic and anti-proliferative agent |
| 06/13/2002 | US20020072510 3-nitrogen-6,7-dioxygen steroids and uses related thereto |
| 06/04/2002 | US6399754 Sugar modified oligonucleotides |
| 05/30/2002 | WO2001042273A3 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 05/30/2002 | US20020065257 17beta-amino and hydroxylamino-11beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 05/29/2002 | EP1208113A2 17beta-acyl-alpha-propynyl-11beta-(cyclic amino)aryl steroids and their derivatives having antagonist hormonal properties |
| 05/28/2002 | US6395713 Cationic lipidcationic lipid |
| 05/28/2002 | US6395492 Derivatized oligonucleotides having improved uptake and other properties |
| 05/23/2002 | US20020061868 Pharmaceutical preparations containing estra-1,3,5(10)-triene derivatives |
| 05/16/2002 | WO2002000680A3 Cationic steroid derivatives for gene delivery |
| 05/16/2002 | US20020058649 Administering during follicular phase of female menstrual cycle and in luteal phase, a competitive progesterone antagonist, which is less than an ovulation-inhibiting dose and less than an abortion-inductive dose |
| 05/07/2002 | US6383814 Cationic amphiphiles for intracellular delivery of therapeutic molecules |
| 05/02/2002 | WO2001074840A3 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregna 21-substituted 19-norpregnadienedione as antiprogestational agents |
| 04/18/2002 | US20020045774 Antigestagenically active steroids with a fluorinated 17-alpha-alkyl chain |
| 04/18/2002 | DE10049736A1 17alpha-Fluoralkylsteroide, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen 17alpha-Fluoroalkyl steroids, processes for their preparation and pharmaceutical compositions containing them |
| 04/17/2002 | EP1196428A1 11$g(b)-ARYL-17,17-SPIROTHIOLANE-SUBSTITUTED STEROIDS |
| 04/17/2002 | EP0970103B1 Antigestagenic steroids with a fluorinated 17alpha-alkyl chain |
| 04/04/2002 | WO2002026759A2 17α FLUOROALKYL STEROIDS, METHOD FOR PRODUCING THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID COMPOUNDS |
| 04/04/2002 | CA2422056A1 17.alpha. fluoroalkyl steroids, method for producing the same and pharmaceutical compositions containing said compounds |
| 04/02/2002 | US6365582 S-substitute 11β-benzaldoxime-estra-4, 9-diene-carbonic acid thiolesters, method for the production thereof and pharmaceutical preparations containing these compounds |
| 03/28/2002 | WO2002000679A3 9.alpha.-chloro-6.alpha.-fluoro-17.alpha.-hydroxy-16-methyl-17-beta-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha. by a cyclic acyl group |
| 03/27/2002 | EP1189923A1 Aromatic and heterocyclic derivatives of phytosterols and/or phytostanols for use in treating or preventing cardiovascular disease |
| 03/20/2002 | EP1187846A2 11beta long-chain substituted estratrienes, method for their production, pharmaceutical preparations containing said 11beta long-chain substituted estratrienes, and their use for producing medicaments |
| 03/19/2002 | US6358931 Oligonucletide conjugated to imidazole; intercalation and coordination compounds; medical diagnosis, gene therapy; antisense agents |
| 03/14/2002 | US20020032181 For therapy of conditions or diseases that are estrogen-dependent, i.e., are estrogen-induced or estrogen-stimulated |
| 03/14/2002 | US20020032180 For therapy of conditions or diseases that are estrogen-dependent, i.e., are estrogen-induced or estrogen-stimulated |
| 03/12/2002 | US6355630 Estra-1,3,5(10)-triene-7α-thioethers |
| 03/07/2002 | US20020028929 Estradiol derivative and immunoassay using the same |
| 02/14/2002 | WO2002012266A1 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
| 02/14/2002 | WO2002012265A1 6.ALPHA., 9.ALPHA.-DIFLUORO-17.ALPHA.-`(2-FURANYLCARBOXYL) OXY!-11.BETA.-HYDROXY-16.ALPHA.-METHYL-3-OXO-ANDROST-1,4,-DIENE-17-CARBOTHIOIC ACID S-FLUOROMETHYL ESTER AS AN ANTI-INFLAMMATORY AGENT |
| 02/14/2002 | WO2001076531A3 Bile acid containing prodrugs with enhanced bioavailability |
| 02/14/2002 | CA2634715A1 6.alpha.,9.alpha.-difluoro-17.alpha.-[(2-furanylcarboxyl)oxy}-11.beta.-hydroxy-16.alpha-methyl-3-oxo-androsta-1,4-diene-17.beta.carbothioic acids-fluoromethyl ester as an anti-inflammatory agent |
| 02/14/2002 | CA2417826A1 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
| 02/06/2002 | EP1177206A1 3alpha-hydroxy-3beta methoxymethyl-21-heterocycle substituted steroids with anaesthetic activity |
| 01/31/2002 | US20020013282 Transfecting a cell comprising by contacting the cell with a biologically active nucleic acid molecule in the presence of a cationic lipid which can be protonated; cationic amphiphiles to transport drugs into cells; gene therapy |
| 01/22/2002 | US6340688 Administering to female during menstrual cycle amount of competitive progesterone antagonist which is less than ovulation-inhibiting dose and less than abortion-inductive dose |
| 01/16/2002 | EP1019095B1 Method for the preparation of facial metal tricarbonyl compounds and their use in the labelling of biologically active substrates |
| 01/15/2002 | US6339077 Substituted 4-benzylaminoquinolines and their hetero analogs, process for their preparation, pharmaceuticals containing these compounds and use thereof |
| 01/15/2002 | US6339066 Antisense oligonucleotides which have phosphorothioate linkages of high chiral purity and which modulate βI, βII, γ, δ, Ε, ζ and η isoforms of human protein kinase C |
| 01/10/2002 | US20020004202 In vivo screen using chemical inducers of dimerization |
| 01/03/2002 | WO2002000680A2 Cationic steroid derivatives for gene delivery |
| 01/03/2002 | WO2002000679A2 9.alpha.-chloro-6.alpha.-fluoro-17.alpha.-hydroxy-16-methyl-17-beta-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha. by a cyclic acyl group |
| 12/18/2001 | US6331524 Organ-specific targeting of cationic amphiphile / DNA complexes for gene therapy |
| 12/13/2001 | DE10028193A1 New bile acid conjugates with benzylamino substituted aromatic and heteroaromatic compounds useful for prevention and treatment of gall stones |
| 12/12/2001 | CN1326461A Meiosis regulating compounds |
| 12/11/2001 | US6329354 Administering bone active phosphonate, administering estrogen hormone |
| 12/05/2001 | EP0904282B1 Novel cationic cholesteryl derivatives containing cyclic polar groups |
| 12/05/2001 | EP0749437B1 Pharmaceutical uses of steroid derivatives |
| 12/05/2001 | CN1324802A Anti-pregnancy hormone active steroid with fluorated 17 alpha-alkyl-chain |
| 11/27/2001 | CA2025294C Bile acid derivatives, processes for their preparation, and use as pharmaceuticals |
| 11/22/2001 | WO2001087299A1 Aralkyl ester soft drugs |
| 11/22/2001 | CA2407099A1 Aralkyl ester soft drugs |
| 11/13/2001 | US6316432 Antigestagenically active steroids with a flourinated 17 α-alkyl chain |
| 11/08/2001 | WO2001083512A1 3-nitrogen-6,7-dioxygen steroids and uses related thereto |
| 11/08/2001 | CA2418748A1 3-nitrogen-6,7-dioxygen steroids and uses related thereto |
| 11/07/2001 | EP1150993A1 Unsaturated cholestane derivatives and their use for the preparation of meiosis regulating medicaments |
| 11/07/2001 | CN1321166A Propanolamine derivs. linked with bile acid used for treating disorders of lipid metabolism |
| 10/30/2001 | US6310225 Useful as intermediates for producing vitamin d derivates |
| 10/25/2001 | WO2001078606A1 Selective nuclear receptor-targeted systems for delivery of cytotoxins to cancer cells for targeted photodynamic therapy |
| 10/18/2001 | WO2001076531A2 Bile acid containing prodrugs with enhanced bioavailability |
| 10/18/2001 | CA2405151A1 Bile acid containing prodrugs with enhanced bioavailability |
| 10/11/2001 | WO2001074840A2 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregna 21-substituted 19-norpregnadienedione as antiprogestational agents |
| 10/10/2001 | EP1140972A1 New 7-alpha, 17-alpha-bis-alkylated testosterone derivatives and their use in long-term therapy of androgen-dependent diseases |
| 10/04/2001 | EP0529002B1 Fluorescent porphyrin, and fluorescent phthalocyanine - polyethylene glycol, polyol, and saccharide derivatives as fluorescent probes |